NGS Kits Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Nucleotide Sequenced, Type of End User and Key Geographical Regions

The NGS kits market is estimated to grow from USD 1.1 billion in the current year and is anticipated to grow to USD 11.5 billion during the forecast period, till 2035.

NGS KITS MARKET: OVERVIEW

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Nucleotide Sequenced

End-user

Academics and Research Institutes
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Other End-users

Key Geographies

North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Rest of the World

NGS KITS MARKET: GROWTH AND TRENDS

The field of genomic data gathering and analysis has progressed notably since Frederick Sanger introduced a gene sequencing technique in 1977. Improvements in DNA sequencing methods have resulted in notable progress across various healthcare-related research areas, including precision medicine and diagnostics. Specifically, the effect of next generation sequencing (NGS) techniques and NGS testing kits, which facilitate whole genome and whole exome sequencing, has been the most significant. This advanced, rapid genome sequencing method has significantly lowered both the expenses and time required. In comparison to the Human Genome Project (~USD 3 billion), the expense of sequencing an individual genome has significantly dropped (to USD 1,000) with present technologies.

Due to the continuous advancements in NGS testing kits and next generation sequencing kits market, stakeholders also expect that, in the coming decade, the previously mentioned cost might drop to USD 100. It is important to note that this reduction in genome sequencing expenses has resulted in a rise in the number of genomes sequenced worldwide.

Despite the recent advances in the field of genomics, the nucleotide library preparation process still faces several challenges, including requirement of large amounts of input samples, low volume of yield and concerns related to quality of the product. In addition, the manual DNA library / RNA library preparation process is time consuming, requiring extensive manipulation and expensive reagents. Therefore, innovators in the pharmaceutical industry are constantly identifying / developing ways to improve the process of DNA library / RNA library preparation. Amidst other alternatives, the use of NGS library preparation kits has emerged as a viable option for various drug developers and academic / research institutes to overcome the existing challenges associated with conventional DNA library / RNA library preparation methods. These kits require less input material and are capable of generating precise DNA encoded library / RNA libraries with minimum errors. Presently, more than 280 NGS library preparation kits are available in the market; these are compatible with a broad range of sequencing platforms, including Illumina®, Ion Torrent® and BGI NGS platforms. It is worth mentioning that over 3,200 patents related to NGS library preparation kits have been filed / granted in the past few years, demonstrating the continued innovation in NGS kits market. Driven by the increasing demand for gene therapies and the introduction of novel and advanced NGS techniques, the NGS library preparation kits market is anticipated to witness steady market growth during the forecast period.

NGS KITS MARKET: KEY INSIGHTS

The report delves into the current state of the NGS kits market and identifies potential growth opportunities within industry. Some key findings from the report include:

Presently, more than 280 NGS library preparation kits are being offered by close to 60 players; these kits are compatible with a variety of input samples, including purified RNA / DNA and cells.

Leveraging their expertise, stakeholders are offering a myriad of NGS kits for preparing DNA and RNA libraries; majority of these kits require less than 5 ng of input samples
The current market landscape is fragmented, featuring both new entrants and established players; the US is currently considered to be a hub of innovation for NGS library preparation kits.
In pursuit of gaining a competitive edge, NGS library preparation kit providers are presently focusing on expansion of their existing capabilities and augmenting their respective product portfolios.
Over 3,250 patents related to NGS library preparation kits have recently been filed / granted, indicating the heightened pace of innovation in this domain.

Around 70 industry players claim to offer elaborate portfolios of NGS based services, leveraging a variety of second and third generation sequencing technologies.

The market is anticipated to grow at a notable CAGR till 2035; the projected opportunity is likely to be distributed across different type of nucleotide sequenced, end user and key geographical regions.

NGS KITS MARKET: KEY SEGMENTS

DNA Segment is Likely to Capture Majority of the NGS Kits Market Share

In terms of type of nucleotide sequenced, the market is segmented across DNA and RNA. In the current year, the DNA segment captures most of the market share (~ 70%). However, the RNA segment will grow at a higher CAGR of 5.1% during the forecast period.

Hospitals and Clinics are Likely to Capture the Highest NGS Kits Market Share in 2035

In terms of end-users, the market is segmented across hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes and others. Around 45% of the market share will be captured by hospitals and clinics by 2035, followed by pharmaceutical and biotechnology companies capturing 30% of the market share.

North America is Likely to Propel the Growth of NGS Kits Market

In terms of geographical regions, the market is segmented across North America, Europe, Asia Pacific, MENA, Latin America, and rest of the world. Notably, North America will capture the maximum market share of around 40% by 2035.

Example Players in NGS Kits Market

Agilent Technologies
BioDynami
Creative Biogene
New England Biolabs
PerkinElmer
Thermo Fisher Scientific
Abcam
Devyser
Diagenode
Lexogen
Roche
Tecan
Enzynomics
MGI
Takara Bio
TIANGEN Biotech
TransGen Biotech
Vazym

NGS KITS MARKET: RESEARCH COVERAGE

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the next generation sequencing kits market, focusing on key market segments, including [A] type of nucleotide sequenced, [B] type of end user, [C] and [E] key geographical regions.
Market Landscape: A detailed assessment of overall competitive landscape next generation sequencing based on several relevant parameters, such as [A] type of nucleotide sequenced, [B] kit components, [C] quantity of sample required, [D] turnaround time, [E] storage temperature, [F] type of sample used, [G] kit shelf life, [H] type of sequencing and [I] type of sequencing platform used.
Company Competitiveness Analysis: A comprehensive NGS library preparation kits examining factors, such as [A] supplier power and [B] product competitiveness.
Company Profiles: In-depth profiles of NGS library preparation kits providers in North America, Europe and Asia-Pacific, based on several parameters such as [A] year of establishment, [B] location of headquarters, [C] proprietary technology platforms, [D] recent developments and [E] an informed future outlook.
Patent Analysis: An in-depth patent analysis to provide an overview of how the industry is evolving from the R&D perspective such as [A] publication year, [B] geographical region, [C] CPC symbols, [D] patent focus areas, [E] type of applicant and [F] leading industry players.

KEY QUESTIONS ANSWERED IN THIS REPORT

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What is the current global capacity of developers?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

Complimentary PPT Insights Packs
Complimentary Excel Data Packs Covering All Analytical Modules
Up to 15% Complimentary Content Customization
In-Depth Report Walkthrough with the Research Team
Complimentary Report Update if the Report is 6+ Months Old

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Overview of Genome Sequencing
3.3. Types of Genome Sequencing
3.3.1. Next Generation Sequencing
3.3.1.1. Applications of Next Generation Sequencing
3.3.1.1.1. Cancer and Affiliated Biomarker Research
3.3.1.1.2. Diagnostics
3.3.1.1.3. Personalized / Precision Medicine
3.3.1.1.4. Forensics
3.3.1.2. Steps Involved in Next Generation Sequencing
3.3.1.2.1. Library Preparation
3.3.1.2.2. Amplification
3.3.1.2.3. Sequencing
3.3.1.2.4. Bioinformatics Analysis and Data Interpretation
3.3.1.3. Components of Next Generation Sequencing Kits
3.4. Future Perspectives

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Next Generation Sequencing Kits: Overall Market Landscape
4.2.1. Analysis by Type of Nucleotide Sequenced
4.2.2. Analysis by Kit Components
4.2.3. Analysis by Quantity of Sample Required
4.2.4. Analysis by Turnaround Time
4.2.5. Analysis by Storage Temperature
4.2.6. Analysis by Type of Sample Used
4.2.7. Analysis by Kit Shelf Life
4.2.8. Analysis by Type of Sequencing
4.2.9. Analysis by Type of Sequencing Platform Used
4.3. Next Generation Sequencing Kits: List of Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Assumptions and Methodology
5.3. Product Competitiveness Analysis: Competitive Landscape

6. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN NORTH AMERICA

6.1. Chapter Overview
6.2. Agilent Technologies
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. NGS Kit Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. BioDynami
6.3.1. Company Overview
6.3.2. NGS Kit Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Creative Biogene
6.4.1. Company Overview
6.4.2. NGS Kit Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. New England Biolabs
6.5.1. Company Overview
6.5.2. NGS Kit Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. PerkinElmer
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. NGS Kit Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Thermo Fisher Scientific
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. NGS Kit Portfolio
6.7.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN EUROPE

7.1. Chapter Overview
7.2. Abcam
7.2.1 Company Overview
7.2.2. Financial Information
7.2.3. NGS Kit Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Devyser
7.3.1 Company Overview
7.3.2. NGS Kit Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Diagenode
7.4.1 Company Overview
7.4.2. NGS Kit Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Lexogen
7.5.1 Company Overview
7.5.2. NGS Kit Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Roche
7.6.1 Company Overview
7.6.2. Financial Information
7.6.3. NGS Kit Portfolio
7.6.4. Recent Developments and Future Outlook
7.7. Tecan
7.7.1 Company Overview
7.7.2. Financial Information
7.7.3. NGS Kit Portfolio
7.7.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN ASIA PACIFIC

8.1. Chapter Overview
8.2. Enzynomics
8.2.1. Company Overview
8.2.2. NGS Kit Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. MGI
8.3.1. Company Overview
8.3.2. NGS Kit Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Takara Bio
8.4.1. Company Overview
8.4.2. Financial Information
8.4.3. NGS Kit Portfolio
8.4.4. Recent Developments and Future Outlook
8.5. TIANGEN Biotech
8.5.1. Company Overview
8.5.2. NGS Kit Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. TransGen Biotech
8.6.1. Company Overview
8.6.2. NGS Kit Portfolio
8.6.3. Recent Developments and Future Outlook
8.7. Vazyme
8.7.1. Company Overview
8.7.2. NGS Kit Portfolio
8.7.3. Recent Developments and Future Outlook

9. PATENT ANALYSIS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Next Generation Sequencing Kits: Patent Analysis
9.3.1 Analysis by Publication Year
9.3.2. Analysis by Geography
9.3.3. Analysis by CPC Symbols
9.3.4. Emerging Focus Areas
9.3.5. Analysis by Type of Applicant
9.3.6. Leading Players: Analysis by Number of Patents
9.4. Next Generation Sequencing Kits: Patent Benchmarking
9.4.1. Analysis by Patent Characteristics
9.5. Next Generation Sequencing Kits: Patent Valuation
9.6. Leading Patents: Analysis by Number of Citations

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Next Generation Sequencing Kits Market, Till 2035
10.3.1. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of Nucleotide Sequenced
10.3.1.1. Next Generation Sequencing Kits Market for DNA, Till 2035
10.3.1.2. Next Generation Sequencing Market for RNA, Till 2035
10.3.2. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of End User
10.3.2.1. Next Generation Sequencing Kits Market for Academic and Research Institutes, Till 2035
10.3.2.2. Next Generation Sequencing Kits Market for Pharmaceutical and Biotechnology Companies, Till 2035
10.3.2.3. Next Generation Sequencing Kits Market for Hospitals and Clinics, Till 2035
10.3.2.4. Next Generation Sequencing Kits Market for Others, Till 2035
10.3.3. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Geography
10.3.3.1. Next Generation Sequencing Kits Market in North America, Till 2035
10.3.3.2. Next Generation Sequencing Kits Market in Europe, Till 2035
10.3.3.3. Next Generation Sequencing Kits Market in Asia Pacific, Till 2035
10.3.3.4. Next Generation Sequencing Kits Market in Middle East and North Africa, Till 2035
10.3.3.5. Next Generation Sequencing Kits Market in Latin America, Till 2035
10.3.3.6. Next Generation Sequencing Kits Market in Rest of the World, Till 2035

11. CASE STUDY: NEXT GENERATION SEQUENCING TECHNOLOGIES AND SERVICE PROVIDERS

11.1. Chapter Overview
11.2. Historical Evolution of Genome Sequencing
11.2.1. First Generation DNA Sequencers
11.2.2. Second Generation HT-NGS Platforms
11.2.3. Third Generation HT-NGS Platforms
11.2.3.1. Heliscope Single Molecule Sequencer
11.2.3.2. Single Molecule Real Time Sequencer
11.2.3.3. Single Molecule Real Time (RNAP) Sequencer
11.2.3.4. Nanopore DNA Sequencer
11.2.3.5. Multiplex Polony Technology
11.2.3.6. The Ion Torrent Sequencing Technology
11.2.4. Comparison of First, Second and Third Generation technologies
11.3. Next Generation Sequencing Technologies
11.3.1. Analysis by Type of Application
11.4. Next Generation Sequencing Service Providers
11.4.1. Next Generation Sequencing Service Providers: Industry Players
11.4.2. Analysis by Year of Establishment
11.4.3. Analysis by Company Size
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Type of Service Offered
11.5. Next Generation Sequencing Service Providers: Non-Industry Players
11.5.1. Analysis by Year of Establishment
11.5.2. Analysis by Location of Headquarters
11.5.3. Analysis by Type of Service Offered

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

13.1. Chapter Overview
13.2. Company A
13.2.1. Company Snapshot
13.2.2. Interview Transcript: General Manager, Very Large Company, Switzerland

14. APPENDIX 1: TABULATED DATA15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

LIST OF FIGURES

Figure 2.1 Executive Summary: Market Forecast
Figure 2.2 Executive Summary: Overall Market Landscape
Figure 2.3 Executive Summary: Patent Analysis
Figure 3.1 Types of Sequencing
Figure 3.2 Applications of Next Generation Sequencing
Figure 3.3 Steps Involved in Next Generation Sequencing
Figure 4.1 Next Generation Sequencing Kits: Distribution by Type of Nucleotide Sequenced
Figure 4.2 Next Generation Sequencing Kits: Distribution by Kit Components
Figure 4.3 Next Generation Sequencing Kits: Distribution by Quantity of Sample Required
Figure 4.4 Next Generation Sequencing Kits: Distribution by Turnaround Time
Figure 4.5 Next Generation Sequencing Kits: Distribution by Storage Temperature
Figure 4.6 Next Generation Sequencing Kits: Distribution by Type of Sample Used
Figure 4.7 Next Generation Sequencing Kits: Distribution by Kit Shelf Life
Figure 4.8 Next Generation Sequencing Kits: Distribution by Type of Sequencing
Figure 4.9 Next Generation Sequencing Kits: Distribution by Type of Sequencing Platform Used
Figure 4.10 Next Generation Sequencing Kit Providers: Distribution by Year of Establishment
Figure 4.11 Next Generation Sequencing Kit Providers: Distribution by Company Size
Figure 4.12 Next Generation Sequencing Kit Providers: Distribution by Location of Headquarters
Figure 4.13 Leading Players: Distribution by Number of Products
Figure 5.1 Next Generation Sequencing Kits: Dot Plot Analysis
Figure 5.2 Product Competitiveness Analysis: Competitive Landscape
Figure 6.1 Agilent Technologies: Annual Revenues, Since 2016 (USD Billion)
Figure 6.2 PerkinElmer: Annual Revenues, Since 2016 (USD Billion)
Figure 6.3 Thermo Fisher Scientific: Annual Revenues, Since 2016 (USD Billion)
Figure 7.1 Abcam: Annual Revenues, Since 2016 (GBP Million)
Figure 7.2 Roche: Annual Revenues, Since 2016 (CHF Billion)
Figure 7.3 Tecan: Annual Revenues, Since 2016 (CHF Million)
Figure 8.1 Takara Bio: Annual Revenues, Since 2016 (JPY Billion)
Figure 9.1 Patent Analysis: Distribution by Type of Patent
Figure 9.2 Patent Analysis: Distribution by Year of Publication
Figure 9.3 Patent Analysis: Distribution by Location of Patent Jurisdiction (Region-wise)
Figure 9.4 Patent Analysis: Distribution by Location of Patent Jurisdiction (Country-wise)
Figure 9.5 Patent Analysis: Distribution by CPC Symbols
Figure 9.6 Patent Analysis: Emerging Focus Areas
Figure 9.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 9.8 Leading Industry Players: Distribution by Number of Patents
Figure 9.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 9.10 Leading Patent Assignees: Distribution by Number of Patents
Figure 9.11 Patent Benchmarking: Distribution of Leading Industry Player by Patent Characteristics (CPC Symbols)
Figure 9.12 Patent Analysis: Distribution by Age
Figure 9.13 Patent Analysis: Patent Valuation
Figure 10.1 Global Next Generation Sequencing Kits Market, Till 2035 (USD Billion)
Figure 10.2 Next Generation Sequencing Kits: Likely Growth Scenarios
Figure 10.3 Next Generation Sequencing Kits Market: Distribution by Type of Nucleotide Sequenced (USD Billion)
Figure 10.4 Next Generation Sequencing Kits Market for DNA, Till 2035 (USD Billion)
Figure 10.5 Next Generation Sequencing Market for RNA, Till 2035 (USD Billion)
Figure 10.6 Next Generation Sequencing Kits Market: Distribution by Type of End User (USD Billion)
Figure 10.7 Next Generation Sequencing Kits Market for Academic and Research Institutes, Till 2035 (USD Billion)
Figure 10.8 Next Generation Sequencing Kits Market for Pharmaceutical and Biotechnology Companies, Till 2035 (USD Billion)
Figure 10.9 Next Generation Sequencing Kits Market for Hospitals and Clinics, Till 2035 (USD Billion)
Figure 10.10 Next Generation Sequencing Kits Market for Others, Till 2035 (USD Billion)
Figure 10.11 Next Generation Sequencing Kits: Distribution by Geography(USD Billion)
Figure 10.12 Next Generation Sequencing Kits Market in North America, Till 2035 (USD Billion)
Figure 10.13 Next Generation Sequencing Kits Market in Europe, Till 2035 (USD Billion)
Figure 10.14 Next Generation Sequencing Kits Market in Asia Pacific, Till 2035 (USD Billion)
Figure 10.15 Next Generation Sequencing Kits Market in Middle East and North Africa, Till 2035 (USD Billion)
Figure 10.16 Next Generation Sequencing Kits Market in Latin America, Till 2035 (USD Billion)
Figure 10.17 Next Generation Sequencing Kits Market in Rest of the World, Till 2035 (USD Billion)
Figure 11.1 Third Generation HT-NGS Platforms
Figure 11.2 Next Generation Sequencing Technologies: Analysis by Type of Application
Figure 11.3 Next Generation Sequencing Service Providers (Industry Players): Distribution by Year of Establishment
Figure 11.4 Next Generation Sequencing Service Providers (Industry Players): Distribution by Company Size
Figure 11.5 Next Generation Sequencing Service Providers (Industry Players): Distribution by Location of Headquarters
Figure 11.6 Next Generation Sequencing Service Providers (Industry Players): Distribution by Type of Service Offered
Figure 11.7 Next Generation Sequencing Service Providers (Non-Industry Players): Distribution by Year of Establishment
Figure 11.8 Next Generation Sequencing Service Providers (Non-Industry Players): Distribution by Location of Headquarters
Figure 11.9 Next Generation Sequencing Service Providers (Non-Industry Players): Distribution by Type of Service Offered
Figure 12.1 Concluding Remarks: Overall Market Landscape
Figure 12.2 Concluding Remarks: Patent Analysis
Figure 12.3 Concluding Remarks: Market Forecast

LIST OF TABLES

Table 4.1 Next Generation Sequencing Kits: List of Products
Table 4.2 Next Generation Sequencing Kits: Information on Type of Sample Used, Kit Shelf Life, Type of Sequencing and Type of Sequencing Platform Used
Table 4.3 Next Generation Sequencing Kits: List of Providers
Table 6.1 Leading NGS Kit Providers in North America
Table 6.2 Agilent Technologies: Company Snapshot
Table 6.3 Agilent Technologies: NGS Kit Portfolio
Table 6.4 Agilent Technologies: Recent Developments and Future Outlook
Table 6.5 BioDynami: Company Snapshot
Table 6.6 BioDynami: NGS Kit Portfolio
Table 6.7 BioDynami: Recent Developments and Future Outlook
Table 6.8 Creative Biogene: Company Snapshot
Table 6.9 Creative Biogene: NGS Kit Portfolio
Table 6.10 Creative Biogene: Recent Developments and Future Outlook
Table 6.11 New England Biolabs: Company Snapshot
Table 6.12 New England Biolabs: NGS Kit Portfolio
Table 6.13 New England Biolabs: Recent Developments and Future Outlook
Table 6.14 PerkinElmer: Company Snapshot
Table 6.15 PerkinElmer: NGS Kit Portfolio
Table 6.16 PerkinElmer: Recent Developments and Future Outlook
Table 6.17 Thermo Fisher Scientific: Company Snapshot
Table 6.18 Thermo Fisher Scientific: NGS Kit Portfolio
Table 6.19 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.1 Leading NGS Kit Providers in Europe
Table 7.2 Abcam: Company Snapshot
Table 7.3 Abcam: NGS Kit Portfolio
Table 7.4 Abcam: Recent Developments and Future Outlook
Table 7.5 Devyser: Company Snapshot
Table 7.6 Devyser: NGS Kit Portfolio
Table 7.7 Devyser: Recent Developments and Future Outlook
Table 7.8 Diagenode: Company Snapshot
Table 7.9 Diagenode: NGS Kit Portfolio
Table 7.10 Diagenode: Recent Developments and Future Outlook
Table 7.11 Lexogen: Company Snapshot
Table 7.12 Lexogen: NGS Kit Portfolio
Table 7.13 Lexogen: Recent Developments and Future Outlook
Table 7.14 Roche: Company Snapshot
Table 7.15 Roche: NGS Kit Portfolio
Table 7.16 Roche: Recent Developments and Future Outlook
Table 7.17 Tecan: Company Snapshot
Table 7.18 Tecan: NGS Kit Portfolio
Table 7.19 Tecan: Recent Developments and Future Outlook
Table 8.1 Leading NGS Kit Providers in Asia Pacific
Table 8.2 Enzynomics: Company Snapshot
Table 8.3 Enzynomics: NGS Kit Portfolio
Table 8.4 MGI: Company Snapshot
Table 8.5 MGI: NGS Kit Portfolio
Table 8.6 Takara Bio: Company Snapshot
Table 8.7 Takara Bio: NGS Kit Portfolio
Table 8.8 Takara Bio: Recent Developments and Future Outlook
Table 8.9 TIANGEN Biotech: Company Snapshot
Table 8.10 TIANGEN Biotech: NGS Kit Portfolio
Table 8.11 TransGen Biotech: Company Snapshot
Table 8.12 TransGen Biotech: NGS Kit Portfolio
Table 8.13 Vazyme: Company Snapshot
Table 8.14 Vazyme: NGS Kit Portfolio
Table 9.1 Patent Analysis: Prominent CPC Symbols
Table 9.2 Patent Analysis: Most Popular CPC Symbols
Table 9.3 Patent Analysis: List of Top CPC Symbols
Table 9.4 Patent Analysis: Summary of Benchmarking Analysis
Table 9.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 9.6 Patent Portfolio: List of Leading Patents (in terms of Highest Relative Valuation)
Table 9.7 Patent Portfolio: List of Leading Patents (in terms of Number of Citations)
Table 11.1 Comparison of First, Second and Third Generation Sequencing Technologies
Table 11.2 Next Generation Sequencing: List of Available Technologies
Table 11.3 Next Generation Sequencing Service Providers: List of Industry Players
Table 11.4 Next Generation Sequencing Service Providers: List of Non-Industry Players
Table 13.1 Tecan: Company Snapshot
Table 14.1 Next Generation Sequencing Kits: Distribution by Type of Nucleotide Sequenced
Table 14.2 Next Generation Sequencing Kits: Distribution by Kit Components
Table 14.3 Next Generation Sequencing Kits: Distribution by Quantity of Sample Required
Table 14.4 Next Generation Sequencing Kits: Distribution by Turnaround Time
Table 14.5 Next Generation Sequencing Kits: Distribution by Storage Temperature
Table 14.6 Next Generation Sequencing Kits: Distribution by Type of Sample Used
Table 14.7 Next Generation Sequencing Kits: Distribution by Kit Shelf Life
Table 14.8 Next Generation Sequencing Kits: Distribution by Type of Sequencing
Table 14.9 Next Generation Sequencing Kits: Type of Sequencing Platform Used
Table 14.10 Next Generation Sequencing Kit Providers: Distribution by Year of Establishment
Table 14.11 Next Generation Sequencing Kit Providers: Distribution by Company Size
Table 14.12 Next Generation Sequencing Kit Providers: Distribution by Location of Headquarters
Table 14.13 Leading Players: Distribution by Number of Products
Table 14.14 Agilent Technologies: Annual Revenues, Since 2016 (USD Billion)
Table 14.15 PerkinElmer: Annual Revenues, Since 2021 (USD Billion)
Table 14.16 Thermo Fisher Scientific: Annual Revenues, Since 2016 (USD Billion)
Table 14.17 Abcam: Annual Revenues, FY 2016-H1 2021 (GBP Million)
Table 14.18 Roche: Annual Revenues, 2016-H1 2021 (CHF Billion)
Table 14.19 Tecan: Annual Revenues, 2016-H1 2021 (CHF Million)
Table 14.20 Takara Bio: Annual Revenues, FY 2016-Q1 2021 (JPY Billion)
Table 14.21 Patent Analysis: Distribution by Type of Patent
Table 14.22 Patent Analysis: Distribution by Year of Publication
Table 14.23 Patent Analysis: Distribution by Location of Patent Jurisdiction (Region-wise)
Table 14.24 Patent Analysis: Distribution by Location of Jurisdiction (Country-wise)
Table 14.25 Patent Analysis: Distribution by CPC Symbols
Table 14.26 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Table 14.27 Leading Industry Players: Distribution by Number of Patents
Table 14.28 Leading Non-Industry Players: Distribution by Number of Patents
Table 14.29 Leading Patent Assignees: Distribution by Number of Patents
Table 14.30 Patent Analysis: Distribution by Age
Table 14.31 Patent Analysis: Patent Valuation
Table 14.32 Global Next Generation Sequencing Kits Market, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.33 Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of Nucleotide Sequenced (USD Billion)
Table 14.34 Next Generation Sequencing Kits Market for DNA, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.35 Next Generation Sequencing Market for RNA, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.36 Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of End User (USD Billion)
Table 14.37 Next Generation Sequencing Kits Market for Academic and Research Institutes, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.38 Next Generation Sequencing Kits Market for Pharmaceutical and Biotechnology Companies, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.39 Next Generation Sequencing Kits Market for Hospitals and Clinics, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.40 Next Generation Sequencing Kits Market for Others, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.41 Next Generation Sequencing Kits, 2021 and 2035: Distribution by Geography (USD Billion)
Table 14.42 Next Generation Sequencing Kits Market in North America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.43 Next Generation Sequencing Kits Market in Europe, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.44 Next Generation Sequencing Kits Market in Asia-Pacific, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.45 Next Generation Sequencing Kits Market in Middle East and North Africa, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.46 Next Generation Sequencing Kits Market in Latin America, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.47 Next Generation Sequencing Kits Market in Rest of the World, Till 2035: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 14.48 Next Generation Sequencing Technologies: Analysis by Type of Application
Table 14.49 Next Generation Sequencing Service Providers (Industry Players): Distribution by Year of Establishment
Table 14.50 Next Generation Sequencing Service Providers (Industry Players): Distribution by Company Size
Table 14.51 Next Generation Sequencing Service Providers (Industry Players): Distribution by Location of Headquarters
Table 14.52 Next Generation Sequencing Service Providers (Industry Players): Distribution by Type of Service Offered
Table 14.53 Next Generation Sequencing Service Providers (Non-Industry Players): Distribution by Year of Establishment
Table 14.54 Next Generation Sequencing Service Providers (Non-Industry Players): Distribution by Location of Headquarters
Table 14.55 Next Generation Sequencing Service Providers (Non-Industry Players): Distribution by Type of Service Offered

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

10x Genomics
1st BASE
Abcam
ABclonal
Advanced Biological Laboratories (ABL)
Active Motif
Admera Health
Agendia
Agilent Technologies
Agiomix
AgriGenome Labs
Almac Group
Annoroad Gene Technology
ANTISEL
Applied Biological Materials (abm)
Arizona Genomics Institute
Auragen
Australian Genome Research Facility (AGRF)
BD
BGI Genomics
BioChain
BioDynami
Biofidal
Bio-Rad
Biosearch Technologies (Acquired by LGC)
Brigham and Women's Hospital
Brigham Young University
Broad Institute
CD Genomics
CeGaT
Cellecta
CEN4GEN
CENTOGENE
Centre for Cellular and Molecular Platforms

(C-CAMP)

Children's Hospital of Philadelphia
City of Hope
Claret Bioscience
Cold Spring Harbor Laboratory
Columbia Genome Center
Creative Biogene
Dana-Farber Cancer Institute
Dante Labs
De Novo Genomics
Devyser
DiaCarta
Diagenode (Acquired by Hologic)
Diagnomics
Diversigen
DNA Genotek
DNA Link
DNAVision
Durham University
Earlham Institute
Eclipse Bioinnovations
Edinburgh Genomics
Enzo Life Sciences
Enzynomics
EpiGentek
Eurofins Genomics
Fasteris
Firalis
Fluidigm
Fulgent Genetics
Full Genomes Corporation (FGC)
Garvan Institute of Medical Research
Genapsys
Gencove
Gene by Gene
GeneFirst
GENEWIZ
Genome.One
GenomeScan
GenomeStream
Genomics Personalized Health
Genomix4Life
Genosity
Genotypic Technology
GenScript
Genuity Science (Previously known as

WuXi NextCODE)

GenXPro
Guardant Health
Harvard College
HistoGenetics
Icahn Institute for Data Science and Genomic Technology 85. Integrated DNA Technologies
Illinois Institute of Technology
Illumina
Immatics Biotechnologies
Intact Genomics
Johns Hopkins University
Leland Stanford Junior University
Lexogen
LGC
Loop Genomics
Lucigen (Acquired by LGC)
Macrogen
MagBio Genomics
Maryland Genomics
Massachusetts General Hospital
Massachusetts Institute of Technology
Massey University
Mass General Brigham (Previously known as Partners HealthCare)
Max Planck Institute
McGill University
Molecular Cloning Laboratories (MCLAB)
MedGenome
Merck
MGI
Microsynth
MNG Laboratories (Acquired by LabCorp)
MOgene
myGenomics
Natera
National Institute of Health and Medical Research (INSERM)
National Instrumentation Center for Environmental Management
New England Biolabs (NEB)
New York Genome Center (NYGC)
NimaGen
Norgen Biotek
Novogene
Nucleome Informatics
OGT
Oklahoma Medical Research Foundation (OMRF)
Omega Bioservices
Otogenetics
Oxford Nanopore Technologies
Pacific Biosciences (PacBio)
PerkinElmer
Phalanx Biotech
Psomagen
Q2 Solutions
QIAGEN
Quantabio
Quick Biology
Rapid Genomics
RealSeq Biosciences
REPROCELL
Roche
RTL Genomics
SeqLL
SeqMatic
Shanghai Oe Biotech
Source BioScience
Stanford University
StarSEQ
Swift Biosciences (Acquired by IDT)
System Biosciences (SBI)
Takara Bio
Tecan
Tempus
Texas A&M AgriLife
The Sequencing Center
Theragen Etex
Thermo Fisher Scientific
The University of Edinburgh
TIANGEN Biotech
TransGen Biotech
TriLink BioTechnologies
Twist Bioscience
UCLA Health
University of California
University of Delaware
University of Leeds
University of Liverpool
University of Maryland
University of Minnesota
University of Oxford
University of Texas
University of Washington
University of Wisconsin
University of Zurich
UNSW Sydney
Uppsala University
Vazyme Biotech
Veritas
Verogen
Waksman Institute of Microbiology

(Rutgers University)

Washington State University
Washington University
Wuhan Fraser Gene Information
Xcelris Genomics
Yaazh Xenomics
Yale School of Medicine
YouSeq
Zymo Research

Methodology

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a single user license, allowing one user access to the product.	€4314EUR$4,799USD£3,744GBP
SITE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6291EUR$6,999USD£5,461GBP
ENTERPRISE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is an enterprise license, allowing all employees within your organization access to the product.	€16179EUR$17,999USD£14,044GBP